You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
习近平倡进一步发展中医药 走中西医结合道路
阿思达克 05-13 10:08
《新华社》报道,国家主席习近平昨日(12日)在河南省南阳市视察,并先後来到医圣祠和南阳药益宝艾草制品有限公司,了解中医药发展和艾草制品产业发展情况。习近平指出,经过抗击新冠肺炎疫情、非典等重大传染病之後,对中医药的作用有了更深的认识,提倡要发展中医药,注重用现代科学解读中医药学原理,走中西医结合的道路。

消息刺激一众中医药股造高,A股华神科技(000790.SZ)涨停。西藏药业(600211.SH)、葫芦娃(605199.SH)、同仁堂(600085.SH)现升3.7%至9.3%。

港股现代中药集团(01643.HK)、中国中药(00570.HK)现分别升5.7%及1.8%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account